NL-OMON53002
Completed
Not Applicable
Tailored treatment in Older Patients TOP-1: Omission of radiotherapy in elderly patients with low risk breast cancer - TOP-1
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 1200
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •\- age 70 years and older;
- •\- after breast conserving surgery
- •\- tumor \<1cm grade 1\-2 or tumor 1\-2cm grade 1;
- •\- tumor ER\>50% positive, HER2 negative;
- •\- sN0 or sN0(itc);
- •\- R0 resection;
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •\- indication for hormonal therapy;
- •\- bilateral.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
Optimising prescription of treatment in older patients with mild hypertension (high blood pressure) at increased risk of serious adverse eventsHypertensionCirculatory SystemISRCTN18030225niversity of Oxford3,014
Active, not recruiting
Not Applicable
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-001473-24-DEEli Lilly and Company880
Active, not recruiting
Not Applicable
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 17.0Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-001473-24-ATEli Lilly and Company880
Active, not recruiting
Phase 1
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMEUCTR2013-001473-24-GBEli Lilly and Company880
Recruiting
Not Applicable
Efficacy of the CARG Toxicity Score versus clinician estimate for predicting the risk of chemotherapy toxicity in older adults with cancer.ACTRN12616000987460Dr Erin Moth150